Magnus Björkholm
Researcher Next ID · RN-034398
Researcher · Medicine
Karolinska University Hospital
Stockholm, Sweden
- Works count
- 655
- Citation count
- 25,754
- H-index
- 80
- i10-index
- 373
Research interests
Publications
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
Annals of Internal Medicine · 2018 · https://doi.org/10.7326/m17-0028
Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population
Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.66.2866
Acute myeloid leukaemia
Nature Reviews Disease Primers · 2016 · https://doi.org/10.1038/nrdp.2016.10
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Haematologica · 2014 · https://doi.org/10.3324/haematol.2014.107714
Survival and cure of acute myeloid leukaemia in E ngland, 1971‐2006: a population–based study
British Journal of Haematology · 2013 · https://doi.org/10.1111/bjh.12425
Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells
Oncogene · 2012 · https://doi.org/10.1038/onc.2012.441
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2012.42.1925
Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.34.7146
Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.34.8540
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2011.34.7542
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
Blood · 2011 · https://doi.org/10.1182/blood-2011-05-355743
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
Blood · 2010 · https://doi.org/10.1182/blood-2009-11-252072
Activation of Telomerase by Human Cytomegalovirus
JNCI Journal of the National Cancer Institute · 2009 · https://doi.org/10.1093/jnci/djp031
Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells
American Journal Of Pathology · 2008 · https://doi.org/10.2353/ajpath.2008.070845
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
Blood · 2008 · https://doi.org/10.1182/blood-2008-03-143602
Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003
Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.09.0100
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
Seminars in Oncology · 2003 · https://doi.org/10.1053/sonc.2003.50038
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
Blood · 2002 · https://doi.org/10.1182/blood-2002-01-0159
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells
Proceedings of the National Academy of Sciences · 2001 · https://doi.org/10.1073/pnas.071043198
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
Oncogene · 2000 · https://doi.org/10.1038/sj.onc.1203890
A Prognostic Score for Advanced Hodgkin's Disease
New England Journal of Medicine · 1998 · https://doi.org/10.1056/nejm199811193392104
ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS
The Lancet · 1986 · https://doi.org/10.1016/s0140-6736(86)92258-0
INTERFERON THERAPY IN MYELOMATOSIS
The Lancet · 1979 · https://doi.org/10.1016/s0140-6736(79)90770-0
Current projects
No projects listed.